Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02941029 · ClinicalTrials.gov registry record
RADTOX: Measuring Radiation Toxicity Using Circulating DNA
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 68
- Enrollment target
NCT02941029: Completed study, sponsored by University of Florida.
NCT02941029 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02941029 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 68 participants
- Enrollment target
Study Summary
This research study is being done to develop a new test to identify prostate cancer patients at highest risk of radiotherapy-related complications. This research study would allow monitoring of total tissue damage within 24 hours of radiation exposure in blood samples that could give an initial result within a few days that would help clinicians make treatment decisions. Detection of unusual tissue damage at this early time, well before symptoms occur, could allow doctors to tailor interventions that could include patient therapies that would reduce or prevent the problems that occur due to treatment of their cancer.
Interventions
- OTHER Plasma Blood collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-07 |
What the finished NCT02941029 record still lists
NCT02941029 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Plasma Blood collection is the first listed.
NCT02941029 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02941029 about?
NCT02941029 is a clinical study titled "RADTOX: Measuring Radiation Toxicity Using Circulating DNA". This research study is being done to develop a new test to identify prostate cancer patients at highest risk of radiotherapy-related complications. This research study would allow monitoring of total tissue damage within 24 hours of radiation exposure in blood samples that could give an initial resu...
What is the current status of trial NCT02941029?
This trial is currently completed. The enrollment target is 68 participants. The study started on 2016-10. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02941029?
The interventions under investigation include: Plasma Blood collection (OTHER).
Who is sponsoring clinical trial NCT02941029?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia